Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
8,600
Employees8,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
8,600
Employees8,600

ILMN Key Statistics

Market cap
32.21B
Market cap32.21B
Price-Earnings ratio
36.62
Price-Earnings ratio36.62
Dividend yield
—
Dividend yield—
Average volume
2.73M
Average volume2.73M
High today
$216.00
High today$216.00
Low today
$205.51
Low today$205.51
Open price
$208.64
Open price$208.64
Volume
2.06M
Volume2.06M
52 Week high
$309.35
52 Week high$309.35
52 Week low
$112.65
52 Week low$112.65

Stock Snapshot

The current Illumina(ILMN) stock price is $213.13, with a market capitalization of 32.21B. The stock trades at a price-to-earnings (P/E) ratio of 36.62.

During the trading session on 2026-11-07, Illumina(ILMN) shares reached a daily high of $216.00 and a low of $205.51. At a current price of $213.13, the stock is +3.7% higher than the low and still -1.3% under the high.

Trading volume for Illumina(ILMN) stock has reached 2.06M, versus its average volume of 2.73M.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

The stock's 52-week range extends from a low of $112.65 to a high of $309.35.

ILMN News

Simply Wall St 1d
What Illumina Shareholders Got Right - Simply Wall St

...

What Illumina Shareholders Got Right - Simply Wall St
Simply Wall St 3d
Illumina Lands Singapore Genomics Role As Undervalued Narrative Faces A Fresh Test

Illumina (ILMN) just picked up a major role in Singapore's National Precision Medicine Phase III programme, being chosen to sequence roughly 450,000 residents f...

Illumina Lands Singapore Genomics Role As Undervalued Narrative Faces A Fresh Test
Zacks 3d
REGN vs. ILMN: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Regeneron (REGN Quick QuoteREGN - Free Report) and Ill...

REGN vs. ILMN: Which Stock Is the Better Value Option?

Analyst ratings

42%

of 24 ratings
Buy
41.7%
Hold
41.7%
Sell
16.7%

More ILMN News

Zacks 5d
Why Illumina is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways...

Why Illumina is a Top Growth Stock for the Long-Term

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.